Does DEA Registration Change My Medical Marijuana Card? Patient Guide

Last updated Nov 2, 2026

Short answer: DEA’s new registrations are issued to dispensaries, not to patients. Under the federal rule, the certification your state treats as sufficient to dispense is what counts, and a registered dispensary can serve you only within its state medical license. The names of the registered dispensaries are not public, and DOJ has not named them.

Does DEA registration change my medical marijuana card?

DEA’s registration is a business credential. On October 30, 2026, the Justice Department said DEA had begun issuing federal registrations to qualifying state-licensed medical marijuana dispensaries. The DOJ release calls this the first phase of carrying out the April order, which moved products covered by a qualifying state license from Schedule I to Schedule III under 21 U.S.C. 811(d), as set out in the final order.

A state license by itself does not bring federal registration. The applicant must operate under a state medical framework that is consistent with federal law and U.S. treaty obligations. Registered dispensaries must also follow federal rules on security, recordkeeping, inventory controls and other safeguards. Each dispensary had to finish DEA’s pre-registration investigation before its registration was issued.

For you, this means the registration sits with the dispensary. Your card or certification still matters, because the federal rule looks to state law to decide which document is enough.

What does the federal rule say about my card or certification?

Under 21 CFR 1301.13(k)(5), the federal rule accepts a state-deemed certification or other document, electronic ones included, as enough to permit dispensing. The document has to meet four conditions:

Because the rule defers to state law on which document counts, your state’s own requirements for the card or certification are the starting point.

What can a DEA-registered dispensary do for patients?

The DEA’s October 30, 2026 guidance for timely applicants and the April rule set out these activities:

• A registered dispenser may dispense to people whom state law authorizes to possess marijuana for medical purposes, within the limits of its state license (21 CFR 1301.13(k)(1)(C)).
• Registration does not cover manufacturing, distribution, dispensing or use for non-medical purposes (k)(1)(D). DOJ says the order does not authorize recreational marijuana.
• If the state medical marijuana license is suspended, revoked or expires, the DEA registration is suspended automatically (k)(3).
• Timely applicants may dispense, manufacture or distribute schedule III medical marijuana under their state license while their application is pending.
• Timely applicants may deal with other timely applicants and with DEA registrants. For example, a timely distributor can supply a timely dispenser, and a registered dispensary can keep receiving from a timely distributor.
• Timely applicants and registrants may not lawfully deal in schedule III medical marijuana with entities that did not apply between April 28 and June 26, 2026, or that have not applied, until those entities become registrants. DEA says dealing with anyone else could be grounds for denying a timely application or revoking a registration.
• Timely dispensers and distributors may keep possessing, dispensing and distributing inventory acquired before the guidance was issued, including inventory from entities that do not qualify. This provision names dispensers and distributors, not manufacturers.

What were the April 28 to June 26 dates, and can dispensaries still apply?

April 28 to June 26, 2026 is the expedited, or timely, window. An applicant became a timely applicant by submitting a complete application, including the registration fee, in that period, according to the DEA guidance. The guidance leaves out applicants who withdrew, applicants denied by a Final Order, and applicants without a state medical marijuana license.

DEA says it is still handling dispensary applications in phases. In October, DEA opened a new Schedule III registration portal, but that portal is for manufacturers, distributors and labs, not dispensaries. Cannabis Business Times reports that DEA will not prioritize those manufacturer, distributor and lab applications until it has processed timely applicants.

The rule also says DEA will make every effort to process applications submitted within 60 days of publication within six months (k)(7).

DEA released a list of nearly 7,000 timely applicants on October 30: 4,197 dispensaries, 2,086 manufacturers and 710 distributors, per Cannabis Business Times. The list gives business types and states, not names. These are applicant counts, not registrations, so they are a separate figure from the more than 900 initial registrations.

Which states are in the first group, including Florida?

The first registrations cover more than 900 dispensaries in Alabama, Florida, Mississippi, South Dakota, Texas, Virginia and West Virginia. The DOJ release does not break that total down by state.

The applicant list gives a wider picture. Cannabis Business Times reports timely applicants of all business types as Oklahoma 2,442, Florida 812, California 771, Maine 320, Pennsylvania 227 and Missouri 209. MJBizDaily describes Florida as the country’s largest medical-only market. Virginia has legalized adult use but has no licensed adult-use market yet, according to Cannabis Business Times, and it is also in the first registration group.

For context, the Associated Press reports that 40 states have medical marijuana systems, eight more allow low-THC cannabis or CBD oil for medical use, and just Idaho and Kansas prohibit marijuana entirely.

What happens to patients in states with both medical and adult-use licenses?

Some states license both medical and adult-use businesses. The DOJ order does not authorize recreational marijuana, and marijuana outside the order remains Schedule I. The most detailed public example so far involves Minnesota.

Minnesota: an order to show cause

The Minnesota Star Tribune reports that DEA agents delivered an order to a Minneapolis dispensary on October 30. The document is an order to show cause. Marijuana Moment and the Star Tribune describe its main points:

• It says DEA “cannot permit any applicant operating under” Minnesota’s law.
• It says a dual-purpose license, which allows both medical and non-medical dispensing, falls outside the definition of a state medical marijuana license, and that registering such an applicant would be inconsistent with the Controlled Substances Act and treaty obligations.
• It points to veterans who need only veteran identification and an attestation.
• It says Minnesota allows dispensaries to sell what it calls synthetic marijuana products, which Marijuana Moment reports refers to hemp-derived cannabinoids.
• It offers two options: request a hearing with an administrative law judge within 30 days, or submit a corrective action plan.

According to the Star Tribune, none of the listed reasons involved violations of state law. The Minnesota Office of Cannabis Management said the letter does not affect the state law behind its medical and adult-use programs, and that medical cannabis remains available to patients in the state.

Cannabis Business Times reports that 30 Minnesota businesses filed timely applications, 26 of them dispensaries. The state’s other 300-plus dispensary licensees did not take part in the expedited process.

Is the Minnesota order a denial?

Some coverage calls it a denial, or says DEA rejected every dual-license applicant. The document is an order to show cause, and it gives the business a hearing option and a corrective action plan option. There is no published count of how many businesses received similar orders.

An owner who received the Minnesota document said DEA was serving many others with the same document. The Cannabis Regulators Association said businesses in a wide range of states received orders, including some that license only medical cannabis, and that state regulators received no notice. An attorney quoted by the Star Tribune suggested DEA may be testing whether an entire state can be disqualified, rather than judging individual applicants.

DEA has not said what happens to patients at a dispensary that receives an order of this kind.

Does DEA registration change my patient records?

The DEA guidance covers the records registrants must keep. Registrants keep the records that schedule III controlled substances require under 21 CFR part 1304. In a transaction with a timely applicant, those records can include the applicant’s document control number (DCN) where a DEA registration number would otherwise be required. Under 21 CFR 1301.13(k)(4), DEA accepts state-required reports, records and forms to the extent permitted by law.

The DCN check is described as due diligence for businesses. A business dealing with a timely dispenser would collect a copy of that dispenser’s “Marijuana Dispensary Information Submission” confirmation and verify the DCN on DEA’s Diversion Control website. The guidance does not describe this as a consumer lookup tool.

DEA has not said whether patient records change under the new registrations. Questions about employers and drug tests are a separate topic, covered in our medical marijuana card at work guide.

Will my product supply change after November 29, 2026?

DEA’s guidance says timely applicants are expected to complete verification and establish compliant supply chains no later than November 29, 2026. DEA has not said how patient supply will change after that date, or what happens to a dispensary that cannot finish by then.

Several other points bear on supply:

• Timely dispensers and distributors may keep possessing, dispensing and distributing inventory acquired before the guidance, including inventory from entities that do not qualify.
• Manufacturer and distributor applications are still under review, including facility inspections, production controls and quota determinations. The DOJ release does not set a timeline for those reviews.
• Qualifying manufacturers, distributors and dispensaries that applied in the first 60 days and remain pending may continue medical marijuana transactions with other qualified applicants and with newly registered entities.
• Registrants and timely applicants may not deal with entities that did not apply in the window, or have not applied, until those entities become registrants.

Can I look up which dispensaries are registered?

The names of the registered dispensaries are not public, and DOJ has not named them. The DOJ release does not name the registered businesses. The Associated Press reports that the department did not immediately identify the approved businesses. DEA’s list of timely applicants gives business types and states, not names.

The DCN verification is a due-diligence step for businesses. It is not described as a way for consumers to look up a dispensary. Because no names have been published, the registration status of any particular dispensary is an open question.

What about the broader rescheduling hearing and adult-use marijuana?

Adult-use marijuana remains Schedule I while a separate process runs with no clear timeline, according to MJBizDaily. DOJ says broader rescheduling is being considered in that separate administrative proceeding. For background on what this does not cover, our rescheduling is not legalization guide explains the difference, and our marijuana rescheduling page covers the current federal order.

The broader rescheduling hearing ran 11 days and concluded on July 15, 2026. On October 22, DEA’s Chief Administrative Law Judge declined to reopen it for new testimony. He admitted a September 23 Government Accountability Office report into the record and set briefs due October 29 and replies due November 5, according to Cannabis Business Times. The hearing process is on hold until at least November 5. After that, the judge must certify the record and make a nonbinding recommendation to DEA Administrator Terry Cole.

Marijuana Moment notes that state adult-use programs do not use doctors’ written certifications, so it is unclear how adult-use businesses could register even if broader rescheduling is adopted. Our June 2026 DEA hearing analysis covers the hearing in more detail.

Do tax changes or hemp rules affect medical marijuana patients?

Treasury and the IRS said in their April 23 release that they plan to issue guidance on the federal tax consequences of the order. The Treasury release says rescheduling generally removes Section 280E as a bar for businesses that, because of the order, stop trafficking in Schedule I or II substances. It describes these effects for businesses, and it does not describe any change for patients.

A cannabis attorney quoted by the Star Tribune said businesses in dual-market states can miss out on the Schedule III tax benefit even if they are not involved in adult-use sales.

Hemp is a separate matter. According to Vicente LLP, H.R. 6500 pushed back to December 11, 2026 the date for the federal hemp total THC standard and the 0.4 milligram per-container limit. The hemp definition itself was amended in section 781 of Public Law 119-37, which was signed on November 12, 2025. Our delta-9 state legal guide covers state-by-state cannabinoid legality.

Questions about how long THC stays in the body are a separate topic. Our THC detox analysis covers the evidence on THC metabolism and clearance.

What is still open for patients?

As of November 2, 2026, these questions remain open:

• Which dispensaries hold federal registrations. DOJ has not named them.
• Whether patient supply changes after November 29, 2026. DEA has not said.
• What happens to patients at a dispensary that receives an order to show cause. DEA has not said.
• Whether patient records change. DEA has not said.
• What requirements DEA may place on owners, including owners with criminal histories. The Associated Press reports that this remains unclear.
• How DEA will buy and resell marijuana, coordinate with states and set enforcement priorities. The Cannabis Regulators Association has raised these questions.
• How adult-use businesses could register if broader rescheduling is adopted. Marijuana Moment describes this as unclear.
• How dispensary applications outside the timely group will be handled. DEA says it is handling them in phases.

Disclosure: This article may contain affiliate links. If you click a link and make a purchase, we may receive a commission at no additional cost to you. All opinions remain our own.

This content is for informational purposes only and is not legal or medical advice. HealthDataConsortium.org is not affiliated with any government entity or cannabis industry organization.

By HealthDataConsortium.org Research Team